Revenue Cycle Advisory for Pulmonology.

Why Revenue Cycle Management Is Different for Pulmonology

Pulmonology groups operate across three distinct revenue environments: outpatient pulmonary clinics and PFT labs, inpatient hospital ICU critical care and bronchoscopy consults, and sleep medicine diagnostic/PAP management centers.

Coding spans complete pulmonary function testing (PFTs: 94010, 94060, 94726–94729, 94617/94618), navigational and EBUS bronchoscopy (31622–31654), inpatient critical care time (99291/99292) vs. ventilator management (94002–94004 NCCI bundling), sleep studies (95800–95811), and severe asthma biologic J-codes (omalizumab, mepolizumab, benralizumab, dupilumab).

• Coding spans complete pulmonary function testing (PFTs: 94010, 94060, 94726–94729, 94617/94618), navigational and EBUS bronchoscopy (31622–31654), inpatient critical care time (99291/99292) vs. ventilator management (94002–94004 NCCI bundling), sleep studies (95800–95811), and severe asthma biologic J-codes (omalizumab, mepolizumab, benralizumab, dupilumab).
• Alignment with CMS National Correct Coding Initiative (NCCI) PTP edits, MUE unit caps, and regional MAC Local Coverage Determinations (LCDs)
• Pre-bill verification of prior authorization numbers, rendering provider credentials, and site-of-service differentials
• Contractual fee-schedule modeling to catch commercial and Medicare Advantage underpayments at 835ERA posting

Prior Authorization, Medical Necessity & Denial Patterns in Pulmonology

In-lab polysomnography (95810/95811) vs. home sleep apnea testing (HSAT: 95806/G0399) and biologic asthma infusions require strict step-therapy and eosinophil/IgE biomarker prior authorization.

Pulmonologists lose substantial revenue to uncaptured ICU critical care rounding charges, NCCI bundling when ventilator management is billed alongside critical care on the same day, PFT component bundling edits, and biologic J-code denials.

• Front-end eligibility and benefit verification tied directly to scheduled CPT/HCPCS procedure codes and site-of-service POS indicators
• Automated tracking of payer-specific prior authorization validity windows, unit thresholds, and peer-to-peer clinical escalation timelines
• Root-cause categorization of CARC 50 (medical necessity), CARC 97 (bundling/inclusive service), CARC 197 (missing precertification), and CARC 4/16 (modifier/claim data errors)
• Contractual underpayment variance auditing against Medicare Physician Fee Schedule (MPFS), ASC payment rates, and commercial payer fee schedules

Important KPIs, Benchmarks & A/R Economics for Pulmonology Groups

For pulmonology organizations between $5M and $100M+ in net patient revenue, eliminating specialty coding friction, prior authorization write-offs, and silent payer underpayments directly improves cash velocity and operating EBITDA.

Reconciling hospital ICU census lists and PFT/sleep lab diagnostic reads against clinic PM billing queues ensures 100% capture of both hospital and ambulatory pulmonary services.

In-House vs. Outsourced Pulmonology Billing: What to Evaluate in an RCM Partner

Deciding whether to run pulmonology billing internally, operate a hybrid model, or outsource to a specialty RCM company requires looking past headline percentage fees. A billing vendor charging 4% that leaves 6% of net collectible revenue on the table through unappealed CARC 97/50 denials or unworked >90-day A/R costs far more than a disciplined internal or specialty-calibrated operation.

RCM Advisory Partners helps organizations benchmark their current operation before negotiating with vendors, and structures rigorous evaluation criteria when an external partner is warranted.

• Encounter-to-claim charge capture reconciliation across all pulmonology service locations
• Specialty CPT, HCPCS, ICD-10-CM, and modifier accuracy audit for pulmonology
• Prior authorization intake, medical-necessity documentation, and CARC 197/50 denial prevention
• Line-level payer allowable reconciliation and aged >90-day A/R recovery workflow review
• Verify certified coder proficiency in pulmonology CPT/HCPCS hierarchies, NCCI bundling edits, and Medicare LCDs
• Audit true net collection yield against contracted pulmonology fee schedules rather than blended gross adjustments
• Require transparent workqueue visibility on >60 and >90 day A/R and clinical appeal overturn rates

30/60/90-Day Pulmonology Revenue Cycle Diagnostic & Optimization Plan

Our advisory engagements translate pulmonology claim and remittance data into a prioritized 90-day execution roadmap:

1. 01
   Days 1–30: Specialty Claim Audit, Coding Review & Fee Schedule Reconciliation

   Audit a statistically valid sample of paid, denied, and zero-pay pulmonology claims across top commercial and Medicare payers; benchmark CPT/modifier distribution and identify immediate underpayment and denial recovery opportunities.

2. 02
   Days 31–60: Prior Authorization, Scrubber Edit & EHR Template Remediation

   Reconfigure front-end authorization matrices, clinical documentation templates, and clearinghouse NCCI/LCD pre-bill edits to stop preventable denials before 837 submission.

3. 03
   Days 61–90: Aged A/R Recovery, Payer Escalation & Vendor SLA Governance

   Deploy structured appeal playbooks for high-value surgical, diagnostic, or infusion claims, and establish monthly KPI scorecards holding internal leads or external billing partners accountable.